Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
China · Delayed Price · Currency is CNY 21.86
-0.07 (-0.32%)
Aug 6, 2025, 2:45 PM CST
SolarWinds Revenue
Humanwell Healthcare (Group) had revenue of 6.14B CNY in the quarter ending March 31, 2025, a decrease of -3.61%. This brings the company's revenue in the last twelve months to 25.21B, up 2.19% year-over-year. In the year 2024, Humanwell Healthcare (Group) had annual revenue of 25.44B with 3.71% growth.
Revenue (ttm)
25.21B
Revenue Growth
+2.19%
P/S Ratio
1.42
Revenue / Employee
1.43M
Employees
17,650
Market Cap
35.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.44B | 910.74M | 3.71% |
| Dec 31, 2023 | 24.52B | 2.19B | 9.79% |
| Dec 31, 2022 | 22.34B | 1.79B | 8.71% |
| Dec 31, 2021 | 20.55B | -131.18M | -0.63% |
| Dec 31, 2020 | 20.68B | -1.13B | -5.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 41.48B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |